Global Trade Hub QUICK FIND

Factory Supply Semax Semaglutide Tirzepatide Oxytocin Mots-C Adipotide Selank Semax Xyla

Price:	US$ 50 / Box
Minimum Order:	1 box
Payment Terms:	TT/Western Union/Paypal/BTC/Bank Transfer/MoenyGra
Port of Export:	tianjin

Product Details

Model No.:	KY-1	Brand Name:	HY

Certification:	COA
Specification:	Semaglutide injection is used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in overweight adults who may also have high blood pressure, diabetes, or high cholesterol. Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of i'nsulin when blood sugar levels are high. I'nsulin helps move sugar from the blood into other body tissues where it is used for energy. Semaglutide injection also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss. Semax is a kind of nootropic that was extensively developed in Russia in the 1980s-90s. It is used as a treatment for cognitive degeneration and brain damage, especially for victims of stroke. A synthetic form of the adrenocorticotropic hormone, it is delivered into the body via a Semax nasal spray. It works like regular human hormones in counteracting stress brought about by environmental factors. A hormone secreted by the pituitary gland, that stimulates the release of cortisol from the adrenal gland, which in turn regulates glucose metabolism and maintains blood pressure. Retatrutide is an investigational single molecule that activates the body's receptors for three hormones - glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity. It employs a triple-agonist (triple-G) mechanism of action. In addition to being a GLP-1RA, it also targets gastric inhibitory polypeptide receptor (GIPR), and glucagon receptor (GCGR). This has consequently shown increased efficacy benefits in clinical trials, superior to those seen with W, which facilitates around -15% body weight loss. Semaglutide is a polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide 1 receptors (GLP1 AR) and used for the treatment of type 2 diabetes. It has a role as a hypoglycemic agent, a glucagon-like peptide-1 receptor agonist, an anti-obesity agent, a neuroprotective agent and an appetite depressant. It is a polypeptide and a lipopeptide.

Certification:

COA

Specification:

Semaglutide injection is used along with an individualized low-calorie, low-fat diet and exercise program to help with weight loss in overweight adults who may also have high blood pressure, diabetes, or high cholesterol.

Semaglutide injection is in a class of medications called incretin mimetics. It works by helping the pancreas to release the right amount of i'nsulin when blood sugar levels are high. I'nsulin helps move sugar from the blood into other body tissues where it is used for energy. Semaglutide injection also works by slowing the movement of food through the stomach and may decrease appetite and cause weight loss.

Semax is a kind of nootropic that was extensively developed in Russia in the 1980s-90s. It is used as a treatment for cognitive degeneration and brain damage, especially for victims of stroke.

A synthetic form of the adrenocorticotropic hormone, it is delivered into the body via a Semax nasal spray. It works like regular human hormones in counteracting stress brought about by environmental factors.

A hormone secreted by the pituitary gland, that stimulates the release of cortisol from the adrenal gland, which in turn regulates glucose metabolism and maintains blood pressure.

Retatrutide is an investigational single molecule that activates the body's receptors for three hormones - glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity.

It employs a triple-agonist (triple-G) mechanism of action. In addition to being a GLP-1RA, it also targets gastric inhibitory polypeptide receptor (GIPR), and glucagon receptor (GCGR). This has consequently shown increased efficacy benefits in clinical trials, superior to those seen with W, which facilitates around -15% body weight loss.

Semaglutide is a polypeptide that contains a linear sequence of 31 amino acids joined together by peptide linkages. It is an agonist of glucagon-like peptide 1 receptors (GLP1 AR) and used for the treatment of type 2 diabetes.

It has a role as a hypoglycemic agent, a glucagon-like peptide-1 receptor agonist, an anti-obesity agent, a neuroprotective agent and an appetite depressant. It is a polypeptide and a lipopeptide.

Packaging & Delivery

Packaging:	Drum/Bucket/Bottle/Tank/Bag/Carton/Box
Delivery/Lead Time:	1-3
Production Capacity:	Tianjin

Product Description

Chemical name: CAS NO:
Semaglutide 910463-68-2.
Tirzepatide 2023788-19-2.
Retatrutide 2381089-83-2.
Liraglutide 204656-20-2.
GHK-CU 49557-75-7.
Semax 80714-61-0.
Selank 129954-34-3.
Melanotan II 121062-08-6.
Kisspeptin 374675-21-5.
semax 80714-61-0.
DSIP 62568-57-4.
Oxytocin 6233-83-6.
Epithalon 307297-39-8.
Thymosin a1 62304-98-7.
Adipotide 859216- 15-2.

Drug Peptides Sermaglutide CAS:910463-68-2

Product Name Semaglutide
CAS NO 910463-68-2..
MF C187H291N45O59.
Molecular weight Molecular weight.
Purity 98%.
Appearance White Crystalline Powder
Key words Sermaglutide;Sermaglutide powder;Sermaglutide price
Semeglutide is a novel once-weekly subcutaneous GLP-1 analog. Semaglutide is a 1/w subcutaneous long-acting GLP-1 analog developed by Novo Nordisk. Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Semeglutide is a novel once-weekly subcutaneous GLP-1 analog. Semaglutide is a 1/w subcutaneous long-acting GLP-1 analog developed by Novo Nordisk. Compared with liraglutide, semaglutide has a longer aliphatic chain and increased hydrophobicity, but semaglutide is modified with a short chain of PEG, and its hydrophilicity is greatly enhanced. After PEG modification, it can not only bind closely to albumin, cover the enzymatic hydrolysis site of DPP-4, but also reduce renal excretion, prolong the biological half-life, and achieve the effect of long circulation.

Factory Supply Semax Semaglutide Tirzepatide Oxytocin Mots-C Adipotide Selank Semax Xyla

Factory Supply Semax Semaglutide Tirzepatide Oxytocin

SUPPLIER PROFILE
Company:	Tianjin Hangyu
City/State	Tianjin, Tianjin	Country:	China
Business Type:	Export - Manufacturer / Trading Company	Established:	NA
Member Since:	2023	Contact Person	Kelly Yu

SUPPLIER PROFILE

Tianjin Hangyu

City/State/Country -

Tianjin, Tianjin

China

Business Type -

Export - Manufacturer / Trading Company

Established -

Member Since -

2023

Contact Person -

Kelly Yu